Company Description

FlowCardia, Inc. is a medical device company founded in 2002 to design and develop a portfolio of innovative, catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices is a major reason a large number of patients are still referred to coronary and peripheral bypass surgery and lower limb amputation.

The new FlowCardia CROSSER® System coupled with recent data supporting improved long-term outcomes of coronary and peripheral therapies may dramatically increase the number of CTO patients treated with minimally invasive, endovascular techniques.